Amsterdam, 22 October 2009 – Dutch-based leading European stem cell storage bank, Cryo-Save Group N.V. (NYSE Euronext: CRYO) completed its listing on NYSE Euronext Amsterdam today.
Cryo-Save has storage and processing facilities in 5 countries and is operating in 38 countries in Europe, Asia and Africa. With over 115.000 samples stored, Cryo-Save is Europe’s largest adult stem cell storage bank. Cryo-Save shares trade on NYSE Euronext under the symbol 'CRYO' and are denominated in Euros. After opening, the first market price was €6.30 per share. Based on the total number of 9,639,191 shares the total market capitalization of the company at opening price was €60,726,903.
-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextRead moreWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesRead moreTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingRead moreEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeRead moreEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Read moreThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesRead moreThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Regulation
-
About Euronext
Euronext strategic planInnovate for Growth 2027Read moreShaping capital markets for future generations